The HER2 copy number in each sample was normalized on the basis of its content of the “backbone” reference gene that is located at 21q21, which has not been found to exhibit alterations in breast cancer patients [5] and its amplification efficiency was found to be similar to the HER2 gene [13]. This evidence concerns the gene ERBB2 and breast carcinoma.